172 related articles for article (PubMed ID: 19307693)
21. Why are mineralocorticoid receptor antagonists cardioprotective?
Chai W; Danser AH
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):153-62. PubMed ID: 17075718
[TBL] [Abstract][Full Text] [Related]
22. Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy.
Ambroisine ML; Milliez P; Nehme J; Pasquier AL; De Angelis N; Mansier P; Swynghedauw B; Delcayre C
Diabetes Metab; 2004 Sep; 30(4):311-8. PubMed ID: 15525873
[TBL] [Abstract][Full Text] [Related]
23. Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries.
Sztechman D; Czarzasta K; Cudnoch-Jedrzejewska A; Szczepanska-Sadowska E; Zera T
J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30898981
[TBL] [Abstract][Full Text] [Related]
24. Genomic and rapid effects of aldosterone: what we know and do not know thus far.
Hermidorff MM; de Assis LV; Isoldi MC
Heart Fail Rev; 2017 Jan; 22(1):65-89. PubMed ID: 27942913
[TBL] [Abstract][Full Text] [Related]
25. Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
Galuppo P; Bauersachs J
Eur J Clin Invest; 2012 Oct; 42(10):1112-20. PubMed ID: 22536780
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of mineralocorticoid action.
Fuller PJ; Young MJ
Hypertension; 2005 Dec; 46(6):1227-35. PubMed ID: 16286565
[TBL] [Abstract][Full Text] [Related]
27. Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease.
Bravo EL
Curr Hypertens Rep; 2003 Apr; 5(2):122-5. PubMed ID: 12642011
[TBL] [Abstract][Full Text] [Related]
28. Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms.
Fu Y; Vallon V
Nephron Physiol; 2014; 128(1-2):8-16. PubMed ID: 25376899
[TBL] [Abstract][Full Text] [Related]
29. Adrenalectomy amplifies aldosterone induced injury in cardiovascular tissue: an effect attenuated by adrenally derived steroids.
Brem AS; Morris DJ; Li X; Ge Y; Shaw S; Gong R
Steroids; 2013 Mar; 78(3):347-55. PubMed ID: 23287650
[TBL] [Abstract][Full Text] [Related]
30. Mineralocorticoid Receptor and Cardiovascular Disease.
Buonafine M; Bonnard B; Jaisser F
Am J Hypertens; 2018 Oct; 31(11):1165-1174. PubMed ID: 30192914
[TBL] [Abstract][Full Text] [Related]
31. Hypertension and the expanding role of aldosterone.
Mackenzie SM; Connell J
Curr Hypertens Rep; 2006 Jun; 8(3):255-61. PubMed ID: 17147925
[TBL] [Abstract][Full Text] [Related]
32. [Endocrinology of aldosterone].
Ronconi V; Giacchetti G; Boscaro M
Ital Heart J; 2005 May; 6 Suppl 1():5S-15S. PubMed ID: 15945295
[TBL] [Abstract][Full Text] [Related]
33. The new biology of aldosterone.
Connell JM; Davies E
J Endocrinol; 2005 Jul; 186(1):1-20. PubMed ID: 16002531
[TBL] [Abstract][Full Text] [Related]
34. Aldosterone target organ protection by eplerenone.
Rudolph AE; Rocha R; McMahon EG
Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
[TBL] [Abstract][Full Text] [Related]
35. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
Weir MR; Dzau VJ
Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
[TBL] [Abstract][Full Text] [Related]
36. Aldosterone and Mineralocorticoid Receptors-Physiology and Pathophysiology.
Funder JW
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492512
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of aldosterone.
Murin J
Bratisl Lek Listy; 2005; 106(1):3-19. PubMed ID: 15869008
[TBL] [Abstract][Full Text] [Related]
38. Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice.
Garnier A; Bendall JK; Fuchs S; Escoubet B; Rochais F; Hoerter J; Nehme J; Ambroisine ML; De Angelis N; Morineau G; d'Estienne P; Fischmeister R; Heymes C; Pinet F; Delcayre C
Circulation; 2004 Sep; 110(13):1819-25. PubMed ID: 15364804
[TBL] [Abstract][Full Text] [Related]
39. Aldosterone and end-organ damage.
Brown NJ
Curr Opin Nephrol Hypertens; 2005 May; 14(3):235-41. PubMed ID: 15821416
[TBL] [Abstract][Full Text] [Related]
40. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
